Vertex Pharmaceuticals Incorporated shares owned by EULAV Asset Management
Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by EULAV Asset Management
from 13F filings
Historical chart of EULAV Asset Management investment in Vertex Pharmaceuticals Incorporated
Tip: Access up to 7 years of quarterly data
All positions including Vertex Pharmaceuticals Incorporated held by EULAV Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by EULAV Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $12M | 33k | 347.74 |
| 2023-06-30 | $13M | 36k | 351.91 |
| 2023-03-31 | $12M | 38k | 315.07 |
| 2022-12-31 | $12M | 42k | 288.78 |
| 2022-09-30 | $14M | 48k | 289.54 |
| 2022-06-30 | $15M | 54k | 281.79 |
| 2022-03-31 | $16M | 60k | 260.97 |
| 2021-12-31 | $18M | 80k | 219.60 |
| 2021-09-30 | $20M | 108k | 181.39 |
| 2021-06-30 | $29M | 142k | 201.63 |
| 2021-03-31 | $32M | 150k | 214.89 |
| 2020-12-31 | $18M | 78k | 236.35 |
| 2020-09-30 | $13M | 47k | 272.13 |
| 2020-06-30 | $14M | 47k | 290.31 |
| 2020-03-31 | $12M | 51k | 237.94 |
| 2019-12-31 | $13M | 58k | 218.95 |
| 2019-09-30 | $12M | 69k | 169.42 |
| 2019-06-30 | $13M | 72k | 183.38 |
| 2019-03-31 | $13M | 72k | 186.06 |
| 2018-12-31 | $13M | 79k | 165.71 |
| 2018-09-30 | $18M | 95k | 192.74 |
| 2018-06-30 | $18M | 107k | 169.96 |
| 2018-03-31 | $19M | 117k | 162.98 |
| 2017-12-31 | $20M | 133k | 149.86 |
| 2017-09-30 | $19M | 125k | 152.04 |
| 2017-06-30 | $17M | 129k | 128.87 |
| 2017-03-31 | $15M | 137k | 109.35 |
| 2016-12-31 | $11M | 142k | 73.67 |
| 2016-09-30 | $13M | 148k | 87.21 |
| 2016-06-30 | $12M | 136k | 86.02 |
| 2016-03-31 | $12M | 146k | 79.49 |
| 2015-12-31 | $15M | 121k | 125.83 |
| 2015-09-30 | $13M | 122k | 104.14 |
| 2015-06-30 | $3.2M | 26k | 123.46 |
Top funds holding Vertex Pharmaceuticals Incorporated
View all funds holding Vertex Pharmaceuticals Incorporated